Technology

Bruce A. Feinberg, DO, of Cardinal Health Specialty Solutions, leads a panel discussion on how far randomized clinical trials have come, how they could be better, and how using real-world evidence could make research more representative of the population.

As the pandemic wore on, fewer patients with sickle cell disease who did contract COVID-19 needed to be hospitalized.

Interest in the use of digital inhalers is growing, as they may provide real-world evidence about how patients monitor and treat their chronic obstructive pulmonary disease (COPD) and asthma at home, but additional questions need to be answered, according to a recent review.

The findings come from an algorithm that was based on 4 criteria-based tools, including 2 widely-used measures designed to ferret out inappropriate medication prescribing in older adults.

The insulin delivery system was linked with a reduction in hypoglycemia among adults and a decrease in hyperglycemia in both adults and children.

Between coverage years 2017 and 2019, racial-ethnic disparities in diabetes technology use worsened among Medicare beneficiaries with type 1 diabetes.

Findings about the willingness of primary care providers to prescribe artificial pancreas systems have positive implications for increasing access to and reducing disparities around this technology by alleviating the need to see a specialist.

Researchers at the University of Rochester are analyzing facial muscle movements through videos taken over webcams or smartphones to train a machine learning algorithm with the hope that it can predict Parkinson disease at an earlier stage.

Participation in education sessions and frequent web-based monitoring predicted 1-year outcomes of asthma control for adolescents with partly controlled and uncontrolled asthma.

The findings, said the researchers, are an important step toward achieving glucose control with a fully automated closed-loop system for patients with type 1 diabetes.

Results of a systemic review found evidence potentially supporting the use of smart phone applications among mothers with gestational diabetes.

Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, explains why raising the standard of medical knowledge of artificial intelligence (AI) in ophthalmology is important.

There has been significant use of digital tools in specialty pharmacy during the COVID-19 pandemic, but it remains to be seen if that move will remain permanent in addition to other offerings, in a less acute setting of care, said Lance Grady, market access practice director, Avalere Health.

Lower indirect costs and a lower incidence of serious complications offset the higher cost of the advanced hybrid closed-loop insulin system.

The field of ophthalmology had already been moving toward telehealth and artificial intelligence (AI) before the COVID-19 pandemic, but these changes are being accelerated now, making it crucial for ophthalmologists to learn to adapt.

Aaron Lee, MD, an associate professor of ophthalmology at University of Washington, describes how artificial intelligence (AI) is used in ophthalmology now and how it could be utilized in the future.

Certain ophthalmic subspecialties were more well suited for telemedicine use based on what tends to get covered in patient visits, said Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.

Specialty pharmaceuticals have a lot of promise, but patients have to go through hoops to get them. Technology can improve interoperability and create a better patient experience, said Jim Adams, chief innovation officer, AllianceRx Walgreens Prime.

Specialty pharmacy was well positioned during the pandemic because it has a history of embracing digital solutions, said Heather Bonome, PharmD, director of pharmacy at the accreditation agency URAC.

This analysis of health insurance claims data demonstrates rapid increase and sustained high utilization of telemedicine services during the COVID-19 pandemic.

At the fully in-person meeting of the Asembia 2021 Specialty Pharmacy Summit, held in Las Vegas, Nevada, attendees will get multiple sessions looking into the future of specialty pharmacy, as well as sessions on hot topics like telehealth and health equity.

Using data from a nationally representative sample, investigators sought to determine trends in insulin device use.

Researchers conducted a randomized clinical trial to test the efficacy of a hybrid closed-loop (HCL) system among pediatric patients with type 1 diabetes (T1D).

Researchers tested the feasibility of remote monitoring for patients with pulmonary arterial hypertension via smartphones and smartwatches.

Sepsis is poorly understood, difficult to identify, and even harder to predict. Consistent stakeholder involvement may be key to identifying precisely where and how a sepsis early warning system could improve the team-based response to the condition.